👋🏼  Welcome back

Baked in Goodness: The Therapeutic Applications of Rainbow Pie

Rainbow Pie, our latest and most colourful cultivar, provides a variety of therapeutic possibilities through its distinctive composition. Featuring a robust terpene profile comprising linalool, farnesene, limonene, humulene, and caryophyllene1, coupled with a substantial THC content of 27% and 2% CBG, Rainbow Pie provides multifaceted healthcare applications.

Pain management

Rainbow Pie offers patients a vibrant pain management solution. The synergy between its high THC levels and diverse terpenes, including anti-inflammatory agents like humulene and caryophyllene, provides a dual-pronged approach to chronic pain management.

Stimulate appetite

Rainbow Pie's ability to stimulate appetite is attributed to its THC and CBG content. THC, known for its appetite-inducing properties, works in tandem with CBG to address appetite loss in patients2, offering a potential aid for those experiencing diminished appetite.

Regulate mood

Moreover, Rainbow Pie's harmonising interplay between Limonene, renowned for its uplifting properties, and THC, leveraging the entourage effects, may assist patients in mood regulation3. Reports from patients highlight Rainbow Pie's euphoric and relaxing qualities, indicating its potential to contribute to managing mood disorders.

As we delve deeper into the characteristics of this potent strain, Rainbow Pie not only emerges as a unique strain but also as an effective therapeutic option for pain, appetite stimulation, and mood regulation.

References
  1. Fernandes ES, Passos GF, Medeiros R, et al. Anti-inflammatory effects of compounds alpha-humulene and (-)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea. Eur J Pharmacol. 2007;569(3):228-236. doi:10.1016/j.ejphar.2007.04.059
  2. Kirkham TC. Cannabinoids and appetite: food craving and food pleasure. Int Rev Psychiatry. 2009;21(2):163-171. doi:10.1080/09540260902782810
  3. Song Y, Seo S, Lamichhane S, et al. Limonene has anti-anxiety activity via adenosine A2A receptor-mediated regulation of dopaminergic and GABAergic neuronal function in the striatum. Phytomedicine. 2021;83:153474. doi:10.1016/j.phymed.2021.153474